Baroreflex activation therapy in patients with pre-existing implantable cardioverter-defibrillator: compatible, complementary therapies.

Abstract

AIMS The Neo™ System (CVRx) is an implantable device, CE certified for the treatment of resistant hypertension and investigationally used to treat systolic heart failure by electrical stimulation of the carotid baroreceptors. It is unknown whether interaction might exist between the Neo System and implantable cardioverter-defibrillators (ICDs). METHODS… (More)
DOI: 10.1093/europace/eut403

Topics

Cite this paper

@article{Madershahian2014BaroreflexAT, title={Baroreflex activation therapy in patients with pre-existing implantable cardioverter-defibrillator: compatible, complementary therapies.}, author={Navid Madershahian and Maximilian P Scherner and Jochen M{\"{u}ller-Ehmsen and Marcel Halbach and Tilman Hickethier and Ralf Velden and Yeong-Hoon Choi and Jens Wippermann and Thorsten C W Wahlers}, journal={Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology}, year={2014}, volume={16 6}, pages={861-5} }